JPS6130676B2 - - Google Patents

Info

Publication number
JPS6130676B2
JPS6130676B2 JP53101002A JP10100278A JPS6130676B2 JP S6130676 B2 JPS6130676 B2 JP S6130676B2 JP 53101002 A JP53101002 A JP 53101002A JP 10100278 A JP10100278 A JP 10100278A JP S6130676 B2 JPS6130676 B2 JP S6130676B2
Authority
JP
Japan
Prior art keywords
methyl
dioxide
formula
thiazine
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53101002A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5448791A (en
Inventor
Fuisutaa Rudorufu
Tsueraa Pauru
Bindaa Deiitaa
Horomatoka Otsutoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5448791A publication Critical patent/JPS5448791A/ja
Publication of JPS6130676B2 publication Critical patent/JPS6130676B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP10100278A 1977-08-22 1978-08-21 Thiazine derivative Granted JPS5448791A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU78009A LU78009A1 (de) 1977-08-22 1977-08-22 Verfahren zur herstellung von thiazinderivaten

Publications (2)

Publication Number Publication Date
JPS5448791A JPS5448791A (en) 1979-04-17
JPS6130676B2 true JPS6130676B2 (enExample) 1986-07-15

Family

ID=19728681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10100278A Granted JPS5448791A (en) 1977-08-22 1978-08-21 Thiazine derivative

Country Status (15)

Country Link
US (1) US4187303A (enExample)
JP (1) JPS5448791A (enExample)
AU (1) AU3891778A (enExample)
BE (1) BE869866A (enExample)
CH (1) CH640540A5 (enExample)
DE (1) DE2835760A1 (enExample)
DK (1) DK370278A (enExample)
FR (1) FR2401167A1 (enExample)
GB (1) GB2002771B (enExample)
IL (1) IL55371A0 (enExample)
IT (1) IT1098283B (enExample)
LU (1) LU78009A1 (enExample)
NL (1) NL7808672A (enExample)
SE (1) SE7808819L (enExample)
ZA (1) ZA784624B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61156673U (enExample) * 1985-03-20 1986-09-29

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
US4914101A (en) * 1987-06-10 1990-04-03 Pfizer Inc. 3,4-Dihydro-2-alkyl-3-oxo-n-aryl-2H-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT399880B (de) * 1992-07-03 1995-08-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
US5246050A (en) * 1992-07-10 1993-09-21 The Goodyear Tire & Rubber Company Tubeless shield and assembly
CA2567223A1 (en) * 2004-05-19 2005-11-24 Boehringer Ingelheim International Gmbh Treatment of diseases associated with altered level of amyloid beta peptides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
GB1308533A (en) 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
US3646021A (en) * 1970-07-16 1972-02-29 Warner Lambert Pharmaceutical 4 - hydroxy - 3 - furylcarbamyl - 2h - 1 2-benzothiazine 1 1-dioxides and process thereof
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3808205A (en) * 1971-09-10 1974-04-30 Warner Lambert Co Process for the preparation of 4-hydroxy-3-carbamyl-2h-1,2-benzothiazine 1,1-dioxides and 4-hydroxy-3(2h)-1,2-benzothiazine carboxylate-1,1-dioxides
US3714155A (en) * 1971-09-27 1973-01-30 Warner Lambert Co 4-hydroxy-2,n-dimethyl-2h-1,2-benzothiazine-3-carboxanilide1,1-dioxide and process therefor
US3821211A (en) * 1972-03-10 1974-06-28 Warner Lambert Co Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolycarbamoyl)-2-methyl-2h-1,2-benzothiazine 1,1-dioxide
IL47877A (en) 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
DE2534689B2 (de) 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
MC1135A1 (fr) * 1976-02-23 1977-11-18 Hoffmann La Roche Derives de thiazine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61156673U (enExample) * 1985-03-20 1986-09-29

Also Published As

Publication number Publication date
DK370278A (da) 1979-02-23
LU78009A1 (de) 1979-05-23
BE869866A (fr) 1979-02-21
AU3891778A (en) 1980-02-21
CH640540A5 (de) 1984-01-13
SE7808819L (sv) 1979-02-23
GB2002771B (en) 1982-05-26
FR2401167A1 (fr) 1979-03-23
ZA784624B (en) 1979-08-29
US4187303A (en) 1980-02-05
IT1098283B (it) 1985-09-07
DE2835760A1 (de) 1979-03-08
GB2002771A (en) 1979-02-28
FR2401167B1 (enExample) 1981-07-24
IT7826894A0 (it) 1978-08-21
NL7808672A (nl) 1979-02-26
IL55371A0 (en) 1978-10-31
JPS5448791A (en) 1979-04-17

Similar Documents

Publication Publication Date Title
FR2698873A1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
NO145139B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav
LU85635A1 (fr) Nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine,leur preparation et compositions pharmaceutiques a base de ces composes
KR850000609B1 (ko) 5-벤조일-6-클로로(또는 브로모)-1,2-디히드로-3H-피롤로[1,2-a]피롤-1-카르복실산 유도체의 제조방법
JPS6130676B2 (enExample)
IE44379B1 (en) Thiazolo (3,4-b)isoquinoline derivatives
DK168010B1 (da) Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse
JPS6126546B2 (enExample)
CA1132585A (en) Phenylaminothiophenacetic acids, processes for their preparation and medicaments containing them
US4544655A (en) Antiinflammatory, analgesic, and antirheumatic 4-hydroxy-2-methyl-n-(2-pyridyl)-6-trifluoromethyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide, corresponding compositions, and 3-carboxylic acid lower alkyl ester intermediates
DK165981B (da) Isoxazolderivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
Werner et al. Derivatives of Morphanthridine1
GB1592295A (en) Sulphamoylbenzoic acids
JPH0246035B2 (enExample)
US4228170A (en) 7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds
HU182436B (en) Process for producing 2,3,4,5-tetrahydro-1-benzoxepine-3,5-dion derivatives
JPS6019317B2 (ja) チエノチアジン誘導体及びその製造方法
US4137323A (en) Organic compounds
NO830611L (no) Imidazotiadiazolalkenkarboksylsyreamider, nye mellomprodukter til deres fremstilling, deres fremstilling og deres anvendles i legemidler
US3442890A (en) Substituted 3-benzazocin-16-ones
JPS5867673A (ja) イミドスルフアミド誘導体
AU623018B2 (en) Novel cyclic anthranilic acid acetic acid derivatives and process for the preparation
EP0011854A1 (en) 4-(2'-Pyridylamino)-phenylacetic acid derivatives, process for their preparation, pharmaceuticals containing these compounds and their use
KR820000275B1 (ko) 티아졸린 유도체의 제조법
PT87616B (pt) Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas